It’s time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Tuesday!
Moving stocks are a new partnership, earnings, an acquisition deal and more.
Let’s get into that news below!
Biggest Pre-Market Stock Movers: 10 Top Gainers
- NLS Pharmaceutics (NASDAQ:NLSP) stock is rocketing more than 156% alongside heavy pre-market trading.
- Actelis Networks (NASDAQ:ASNS) shares are soaring over 137% after with Carahsoft.
- MicroAlgo (NASDAQ:MLGO) stock is surging more than 25% despite a lack of news this morning.
- Silk Road Medical (NASDAQ:SILK) shares are increasing over 23% .
- Mustang Bio (NASDAQ:MBIO) stock is gaining more than 22% as it continues a clinical study rally.
- Fly-E Group (NASDAQ:FLYE) shares are rising over 21% after .
- Sonoma Pharmaceuticals (NASDAQ:SNOA) stock is heading more than 21% higher alongside its .
- Clene (NASDAQ:CLNN) shares are climbing over 18% higher on .
- Chegg (NYSE:CHGG) stock is jumping 18% on .
- BioLine Rx (NASDAQ:BLRX) shares are up more than 17% without any clear news this morning.
10 Top Losers
- Aerwins Technologies (NASDAQ:AWIN) stock is crashing over 52% as its .
- Quantum (NASDAQ:QMCO) shares are plummeting more than 41% with the release of its .
- Biolase (NASDAQ:BIOL) stock is diving over 39% .
- Connexa Sports Technologies (NASDAQ:YYAI) shares are tumbling more than 23% on plans for a .
- Interactive Strength (NASDAQ:TRNR) stock is taking an over 22% beating after rallying yesterday.
- Srivaru (NASDAQ:SVMH) shares are sliding more than 15% as it retreats from a recent rally.
- Virpax Pharmaceuticals (NASDAQ:VRPX) stock is dropping over 15% on Tuesday morning.
- Bio-Path (NASDAQ:BPTH) shares are decreasing more than 14% on a .
- Anitra (NYSEMKT:AZTR) stock is falling over 14% today.
- Kineta (NASDAQ:KA) shares close out our pre-market stock movers down more than 12% this morning.
On the date of publication, William White did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.